{"id":129737,"date":"2024-04-17T09:49:59","date_gmt":"2024-04-17T07:49:59","guid":{"rendered":"https:\/\/prod1-sb.designtech.space\/liftt-invests-in-evergreen-for-the-development-of-radiopharmaceuticals\/129737\/"},"modified":"2024-04-17T09:49:59","modified_gmt":"2024-04-17T07:49:59","slug":"liftt-invests-in-evergreen-for-the-development-of-radiopharmaceuticals","status":"publish","type":"post","link":"https:\/\/www.startupbusiness.it\/en\/liftt-invests-in-evergreen-for-the-development-of-radiopharmaceuticals\/129737\/","title":{"rendered":"LIFTT invests in Evergreen for the development of radiopharmaceuticals"},"content":{"rendered":"

Italian venture capital firm LIFTT, together with Petrichor and other participating investors, announce that they have finalized a $26 million investment round in Evergreen Theragnostics,<\/strong> a radiopharmaceutical company engaged in the development of therapeutic solutions, using radiopharmaceuticals, for cancer patients.<\/p>\n

The capital raised secures the advancement of Evergreen’s new pipeline of discoveries into clinical trials, supports the commercialization of its diagnostic agent, and further expands CDMO capabilities to meet growing customer demand.<\/p>\n

“We’ve made progress in our discovery pipeline and are excited to take the next step in development,” James Cook, CEO of Evergreen Theragnostics, said in a statement. <\/strong> As we continue to work with the FDA toward the approval of our Ga-68 DOTATOC diagnostic kit, this new funding will allow us to rapidly evolve our new thermagnostic pair, EVG-321, into clinical trials. In addition, our CDMO business is continuing to grow, thanks to the entry of new customers and the strengthening of our relationships with existing ones. We appreciate the confidence shown by our current and new shareholders in advancing our priorities.”<\/p>\n

Ste<\/b>fano Buono, president of LIFTT and founder and former CEO of Advanced Accelerator Applications (AAA), says, “The radioligand therapy industry is advancing rapidly.<\/strong> The investment in Evergreen Theragnostics reinforces our commitment to this fascinating sector alongside a well-positioned company in the market.”<\/p>\n

“We’ve been following Evergreen since its inception and are excited to partner with James and his team as they bring best-in-class and best-in-class to the clinic, expand their top-tier radiopharmaceutical drug discovery activities, prepare for the commercial launch of their diagnostic product, and further capitalize on the highly specialized expertise needed to build and operate a radiopharmaceutical CDMO,” adds Patrick Lally, partner at Petrichor.<\/strong><\/p>\n

Evergreen has built an efficient and experienced team of scientific, medical, commercial and operational managers and collaborators who are able to continue to develop the innovative solution. In the coming months, Evergreen will continue to plan the launch of the diagnostic drug Octevy, subject to FDA approval. Evergreen Discovery also plans to initiate registration for therapeutic and diagnostic clinical trials for lutetium-177 (177Lu) EVG-321 and gallium-68 (68Ga) EVG-321, a novel pair of therapeutic radiopharmaceuticals that, if successful, could offer new hope to patients with small cell lung cancer.<\/p>\n","protected":false},"excerpt":{"rendered":"

The round, worth a total of $26 million, sees the Italian VC engaged together with other investors including Petrichor<\/p>\n","protected":false},"author":125,"featured_media":137211,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1317],"tags":[1330,1144,1143,1137,1407],"companies":[],"journalist":[1513],"class_list":["post-129737","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-funding-news","tag-deeptech-en","tag-europe-en","tag-investments","tag-italy-en","tag-life-sciences","journalist-emil-abirascid-en"],"featured_sizes_urls":{"thumbnail":{"src":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2024\/06\/thumbnail_Stefano-Buono-Presidente-LIFTT-_2.jpg","width":150,"height":100,"crop":false,"srcset":false,"alt":""},"large":{"src":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2024\/06\/thumbnail_Stefano-Buono-Presidente-LIFTT-_2.jpg","width":1024,"height":681,"crop":false,"srcset":false,"alt":""},"2048x2048":{"src":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2024\/06\/thumbnail_Stefano-Buono-Presidente-LIFTT-_2.jpg","width":1920,"height":1277,"crop":false,"srcset":false,"alt":""}},"acf":[],"yoast_head":"\nLIFTT invests in Evergreen for the development of radiopharmaceuticals<\/title>\n<meta name=\"description\" content=\"The round, worth a total of $26 million, sees the Italian VC engaged together with other investors including Petrichor\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.startupbusiness.it\/en\/liftt-invests-in-evergreen-for-the-development-of-radiopharmaceuticals\/129737\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"LIFTT invests in Evergreen for the development of radiopharmaceuticals\" \/>\n<meta property=\"og:description\" content=\"The round, worth a total of $26 million, sees the Italian VC engaged together with other investors including Petrichor\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.startupbusiness.it\/en\/liftt-invests-in-evergreen-for-the-development-of-radiopharmaceuticals\/129737\/\" \/>\n<meta property=\"og:site_name\" content=\"Startupbusiness.it\" \/>\n<meta property=\"article:published_time\" content=\"2024-04-17T07:49:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2024\/06\/thumbnail_Stefano-Buono-Presidente-LIFTT-_2.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1277\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Emil Abirascid\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@emilabirascid\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Emil Abirascid\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/liftt-invests-in-evergreen-for-the-development-of-radiopharmaceuticals\\\/129737\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/liftt-invests-in-evergreen-for-the-development-of-radiopharmaceuticals\\\/129737\\\/\"},\"author\":{\"name\":\"Emil Abirascid\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/#\\\/schema\\\/person\\\/4e2760db2cb7ca47d635ea3d8d8486dd\"},\"headline\":\"LIFTT invests in Evergreen for the development of radiopharmaceuticals\",\"datePublished\":\"2024-04-17T07:49:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/liftt-invests-in-evergreen-for-the-development-of-radiopharmaceuticals\\\/129737\\\/\"},\"wordCount\":379,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/liftt-invests-in-evergreen-for-the-development-of-radiopharmaceuticals\\\/129737\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.startupbusiness.it\\\/wp-content\\\/uploads\\\/2024\\\/06\\\/thumbnail_Stefano-Buono-Presidente-LIFTT-_2.jpg\",\"keywords\":[\"deeptech\",\"Europe\",\"investments\",\"italy\",\"Life Sciences\"],\"articleSection\":[\"Funding News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/liftt-invests-in-evergreen-for-the-development-of-radiopharmaceuticals\\\/129737\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/liftt-invests-in-evergreen-for-the-development-of-radiopharmaceuticals\\\/129737\\\/\",\"url\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/liftt-invests-in-evergreen-for-the-development-of-radiopharmaceuticals\\\/129737\\\/\",\"name\":\"LIFTT invests in Evergreen for the development of radiopharmaceuticals\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/liftt-invests-in-evergreen-for-the-development-of-radiopharmaceuticals\\\/129737\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/liftt-invests-in-evergreen-for-the-development-of-radiopharmaceuticals\\\/129737\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.startupbusiness.it\\\/wp-content\\\/uploads\\\/2024\\\/06\\\/thumbnail_Stefano-Buono-Presidente-LIFTT-_2.jpg\",\"datePublished\":\"2024-04-17T07:49:59+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/#\\\/schema\\\/person\\\/4e2760db2cb7ca47d635ea3d8d8486dd\"},\"description\":\"The round, worth a total of $26 million, sees the Italian VC engaged together with other investors including Petrichor\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/liftt-invests-in-evergreen-for-the-development-of-radiopharmaceuticals\\\/129737\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/liftt-invests-in-evergreen-for-the-development-of-radiopharmaceuticals\\\/129737\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.startupbusiness.it\\\/wp-content\\\/uploads\\\/2024\\\/06\\\/thumbnail_Stefano-Buono-Presidente-LIFTT-_2.jpg\",\"contentUrl\":\"https:\\\/\\\/www.startupbusiness.it\\\/wp-content\\\/uploads\\\/2024\\\/06\\\/thumbnail_Stefano-Buono-Presidente-LIFTT-_2.jpg\",\"width\":1920,\"height\":1277},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/\",\"name\":\"Startupbusiness.it\",\"description\":\"May the Force be with you!\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/#\\\/schema\\\/person\\\/4e2760db2cb7ca47d635ea3d8d8486dd\",\"name\":\"Emil Abirascid\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/84e46190ac811c9c62650621ceca8f65c1e967d6b06e6352fe183145dba0d7e9?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/84e46190ac811c9c62650621ceca8f65c1e967d6b06e6352fe183145dba0d7e9?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/84e46190ac811c9c62650621ceca8f65c1e967d6b06e6352fe183145dba0d7e9?s=96&d=mm&r=g\",\"caption\":\"Emil Abirascid\"},\"description\":\"Emil Abirascid (\u30a8\u30df\u30fc\u30eb\u30fb\u30a2\u30d3\u30e9\u30b7\u30c3\u30c9), giornalista, fondatore e direttore di Startupbusiness, il primo magazine sull\u2019ecosistema startup e innovazione italiano. Co-fondatore di Designtech, l\u2019hub di innovazione che avvicina il mondo del design con quello della tecnologia. Advisor di Austrian Business Agency, Emil Banca, Fondazione Symbola, Fondazione Quadrans. Partecipa regolarmente a incontri, convegni, conferenze dedicate all\u2019ecosistema dell\u2019innovazione. E\u2019 stato co-organizzatore degli Italian Innovation Day and Series che si sono svolti dal dal 2016 al 2020 nelle citt\u00e0 di Tokyo in Giappone, Melbourne, Adelaide, Perth, Canberra in Australia e Singapore e co-organizzatore dell\u2019Italy India Innovation Day di AIICP 2021 e 2022. Ha curato il volume \u2018L\u2019innovazione che non ti aspetti. Contesti e visioni per l\u2019impresa\u2019 , l\u2019edizione italiana di \u2018La startup digitale, guida pratica step by step\u2019 e ha scritto la prefazione all\u2019edizione italiana de \u2018La quarta era\u2019 di Byron Reese, ed \u00e8 co-autore di \u2018Cosa e Dove: strategie digitali di ricerca del lavoro\u2019, tutti editi da FrancoAngeli. In passato \u00e8 stato curatore di StartupDigest Italy, coordinatore scientifico del Forum per la Ricerca della Provincia Autonoma di Trento, board member di TechChill Milano advisor di di ScaleIT , ha collaborato con Il Sole 24 Ore \u00e8 stato direttore di Innov\u2019azione, bimestrale edito da Apsti, ha collaborato con Corriere Innovazione ed \u00e8 stato presidente del comitato di selezione del Premio Marzotto e advisor di Cetif-Universit\u00e0 Cattolica Milano.\",\"sameAs\":[\"https:\\\/\\\/www.abirascid.com\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/in\\\/emilabirascid\",\"https:\\\/\\\/x.com\\\/emilabirascid\"],\"url\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/author\\\/emil-abirascid\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"LIFTT invests in Evergreen for the development of radiopharmaceuticals","description":"The round, worth a total of $26 million, sees the Italian VC engaged together with other investors including Petrichor","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.startupbusiness.it\/en\/liftt-invests-in-evergreen-for-the-development-of-radiopharmaceuticals\/129737\/","og_locale":"en_US","og_type":"article","og_title":"LIFTT invests in Evergreen for the development of radiopharmaceuticals","og_description":"The round, worth a total of $26 million, sees the Italian VC engaged together with other investors including Petrichor","og_url":"https:\/\/www.startupbusiness.it\/en\/liftt-invests-in-evergreen-for-the-development-of-radiopharmaceuticals\/129737\/","og_site_name":"Startupbusiness.it","article_published_time":"2024-04-17T07:49:59+00:00","og_image":[{"width":1920,"height":1277,"url":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2024\/06\/thumbnail_Stefano-Buono-Presidente-LIFTT-_2.jpg","type":"image\/jpeg"}],"author":"Emil Abirascid","twitter_card":"summary_large_image","twitter_creator":"@emilabirascid","twitter_misc":{"Written by":"Emil Abirascid","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.startupbusiness.it\/en\/liftt-invests-in-evergreen-for-the-development-of-radiopharmaceuticals\/129737\/#article","isPartOf":{"@id":"https:\/\/www.startupbusiness.it\/en\/liftt-invests-in-evergreen-for-the-development-of-radiopharmaceuticals\/129737\/"},"author":{"name":"Emil Abirascid","@id":"https:\/\/www.startupbusiness.it\/en\/#\/schema\/person\/4e2760db2cb7ca47d635ea3d8d8486dd"},"headline":"LIFTT invests in Evergreen for the development of radiopharmaceuticals","datePublished":"2024-04-17T07:49:59+00:00","mainEntityOfPage":{"@id":"https:\/\/www.startupbusiness.it\/en\/liftt-invests-in-evergreen-for-the-development-of-radiopharmaceuticals\/129737\/"},"wordCount":379,"commentCount":0,"image":{"@id":"https:\/\/www.startupbusiness.it\/en\/liftt-invests-in-evergreen-for-the-development-of-radiopharmaceuticals\/129737\/#primaryimage"},"thumbnailUrl":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2024\/06\/thumbnail_Stefano-Buono-Presidente-LIFTT-_2.jpg","keywords":["deeptech","Europe","investments","italy","Life Sciences"],"articleSection":["Funding News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.startupbusiness.it\/en\/liftt-invests-in-evergreen-for-the-development-of-radiopharmaceuticals\/129737\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.startupbusiness.it\/en\/liftt-invests-in-evergreen-for-the-development-of-radiopharmaceuticals\/129737\/","url":"https:\/\/www.startupbusiness.it\/en\/liftt-invests-in-evergreen-for-the-development-of-radiopharmaceuticals\/129737\/","name":"LIFTT invests in Evergreen for the development of radiopharmaceuticals","isPartOf":{"@id":"https:\/\/www.startupbusiness.it\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.startupbusiness.it\/en\/liftt-invests-in-evergreen-for-the-development-of-radiopharmaceuticals\/129737\/#primaryimage"},"image":{"@id":"https:\/\/www.startupbusiness.it\/en\/liftt-invests-in-evergreen-for-the-development-of-radiopharmaceuticals\/129737\/#primaryimage"},"thumbnailUrl":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2024\/06\/thumbnail_Stefano-Buono-Presidente-LIFTT-_2.jpg","datePublished":"2024-04-17T07:49:59+00:00","author":{"@id":"https:\/\/www.startupbusiness.it\/en\/#\/schema\/person\/4e2760db2cb7ca47d635ea3d8d8486dd"},"description":"The round, worth a total of $26 million, sees the Italian VC engaged together with other investors including Petrichor","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.startupbusiness.it\/en\/liftt-invests-in-evergreen-for-the-development-of-radiopharmaceuticals\/129737\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.startupbusiness.it\/en\/liftt-invests-in-evergreen-for-the-development-of-radiopharmaceuticals\/129737\/#primaryimage","url":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2024\/06\/thumbnail_Stefano-Buono-Presidente-LIFTT-_2.jpg","contentUrl":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2024\/06\/thumbnail_Stefano-Buono-Presidente-LIFTT-_2.jpg","width":1920,"height":1277},{"@type":"WebSite","@id":"https:\/\/www.startupbusiness.it\/en\/#website","url":"https:\/\/www.startupbusiness.it\/en\/","name":"Startupbusiness.it","description":"May the Force be with you!","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.startupbusiness.it\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.startupbusiness.it\/en\/#\/schema\/person\/4e2760db2cb7ca47d635ea3d8d8486dd","name":"Emil Abirascid","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/84e46190ac811c9c62650621ceca8f65c1e967d6b06e6352fe183145dba0d7e9?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/84e46190ac811c9c62650621ceca8f65c1e967d6b06e6352fe183145dba0d7e9?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/84e46190ac811c9c62650621ceca8f65c1e967d6b06e6352fe183145dba0d7e9?s=96&d=mm&r=g","caption":"Emil Abirascid"},"description":"Emil Abirascid (\u30a8\u30df\u30fc\u30eb\u30fb\u30a2\u30d3\u30e9\u30b7\u30c3\u30c9), giornalista, fondatore e direttore di Startupbusiness, il primo magazine sull\u2019ecosistema startup e innovazione italiano. Co-fondatore di Designtech, l\u2019hub di innovazione che avvicina il mondo del design con quello della tecnologia. Advisor di Austrian Business Agency, Emil Banca, Fondazione Symbola, Fondazione Quadrans. Partecipa regolarmente a incontri, convegni, conferenze dedicate all\u2019ecosistema dell\u2019innovazione. E\u2019 stato co-organizzatore degli Italian Innovation Day and Series che si sono svolti dal dal 2016 al 2020 nelle citt\u00e0 di Tokyo in Giappone, Melbourne, Adelaide, Perth, Canberra in Australia e Singapore e co-organizzatore dell\u2019Italy India Innovation Day di AIICP 2021 e 2022. Ha curato il volume \u2018L\u2019innovazione che non ti aspetti. Contesti e visioni per l\u2019impresa\u2019 , l\u2019edizione italiana di \u2018La startup digitale, guida pratica step by step\u2019 e ha scritto la prefazione all\u2019edizione italiana de \u2018La quarta era\u2019 di Byron Reese, ed \u00e8 co-autore di \u2018Cosa e Dove: strategie digitali di ricerca del lavoro\u2019, tutti editi da FrancoAngeli. In passato \u00e8 stato curatore di StartupDigest Italy, coordinatore scientifico del Forum per la Ricerca della Provincia Autonoma di Trento, board member di TechChill Milano advisor di di ScaleIT , ha collaborato con Il Sole 24 Ore \u00e8 stato direttore di Innov\u2019azione, bimestrale edito da Apsti, ha collaborato con Corriere Innovazione ed \u00e8 stato presidente del comitato di selezione del Premio Marzotto e advisor di Cetif-Universit\u00e0 Cattolica Milano.","sameAs":["https:\/\/www.abirascid.com\/","https:\/\/www.linkedin.com\/in\/emilabirascid","https:\/\/x.com\/emilabirascid"],"url":"https:\/\/www.startupbusiness.it\/en\/author\/emil-abirascid\/"}]}},"author_name":"Emil Abirascid","categories_names":["Funding News"],"_links":{"self":[{"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/posts\/129737","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/users\/125"}],"replies":[{"embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/comments?post=129737"}],"version-history":[{"count":0,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/posts\/129737\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/media\/137211"}],"wp:attachment":[{"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/media?parent=129737"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/categories?post=129737"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/tags?post=129737"},{"taxonomy":"companies","embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/companies?post=129737"},{"taxonomy":"journalist","embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/journalist?post=129737"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}